MICROANEURYSM FORMATION RATE AS A PREDICTIVE MARKER FOR PROGRESSION TO CLINICALLY SIGNIFICANT MACULAR EDEMA IN NONPROLIFERATIVE DIABETIC RETINOPATHY

被引:53
作者
Haritoglou, Christos [1 ]
Kernt, Marcus [1 ]
Neubauer, Aljoscha [1 ]
Gerss, Joachim [2 ]
Oliveira, Carlos Manta [3 ]
Kampik, Anselm [1 ]
Ulbig, Michael [1 ]
机构
[1] Univ Munich, Dept Ophthalmol, D-80336 Munich, Germany
[2] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
[3] Crit Hlth SA, Coimbra, Portugal
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2014年 / 34卷 / 01期
关键词
diabetic macular edema; progression; microaneurysm turnover; TURNOVER;
D O I
10.1097/IAE.0b013e318295f6de
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the predictive value of microaneurysm (MA) formation rate concerning the development of clinically significant macular edema (CSME) in patients with mild-to-moderate nonproliferative diabetic retinopathy as evaluated by an automated analysis of central field fundus 30 degrees photographs. Methods: Two hundred and eighty-seven eyes were included in the study. Photographs obtained at Day 0, at 6, and 12 months were analyzed using the RetmarkerDR software (Critical Health SA) in a masked manner, and the MA formation rate was documented. A threshold of a calculated MA formation rate of 2 or more was chosen to consider a patient "positive." The ability to predict CSME development was then calculated for a period of up to 5 years. HbA1c values, blood pressure, or duration of diabetes were also evaluated. Results: The study population consisted of 89 male and 59 female patients with a mean age of 57.6 years, a mean HbA1c of 7.8, and a mean duration of diabetes of 12.3 years. Forty-seven of 287 eyes (16.4%) developed CSME during follow-up. An increased MA formation rate of > 2 MA was clearly associated with development of CSME. Using the automated analysis and a threshold of 2 or more new MA, the authors were able to identify 70.2% of the eyes that developed CSME during follow-up ("true positive") and using a threshold of up to 2 new MA, 71.7% of the patients that did not develop CSME ("true negative"). No significant differences concerning baseline and 1-year HbA1c levels within patient eyes that developed CSME compared with patient eyes below or over the calculated threshold of 2 MA (P = 0.554 and P = 0.890, respectively) were seen. The positive and negative predictive value was calculated to be 33% versus 92.5%, sensitivity was 70%, and specificity was 72%. Conclusion: Using the RetmarkerDR software, the authors were able to identify patients with higher risk to develop CSME during follow-up using a threshold of 2 or more MA formation rate. Together with the high negative predictive value, the automated analysis may help to determine the individual risk of a patient to develop sight-threatening complications related to diabetic retinopathy and schedule individual screening intervals.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 20 条
[1]   DIAGNOSTIC-TESTS-2 - PREDICTIVE VALUES .4. [J].
ALTMAN, DG ;
BLAND, JM .
BRITISH MEDICAL JOURNAL, 1994, 309 (6947) :102-102
[2]  
[Anonymous], 1991, Ophthalmology, V98, P786
[3]  
[Anonymous], EVIDENCE BASED OPHTH
[4]  
Bernardes R, 2005, IM PROC ICIP 2005 IE, V1, P1133
[5]   Computer-Assisted Microaneurysm Turnover in the Early Stages of Diabetic Retinopathy [J].
Bernardes, Rui ;
Nunes, Sandrina ;
Pereira, Ivania ;
Torrent, Teresa ;
Rosa, Andreia ;
Coelho, Dalila ;
Cunha-Vaz, Jose .
OPHTHALMOLOGICA, 2009, 223 (05) :284-291
[6]   Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium [J].
Csaky, Karl G. ;
Richman, Elaine A. ;
Ferris, Frederick L., III .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) :479-489
[7]  
Ferreira J, 2005, 3 EUR MED BIOL ENG C
[8]   Automated microaneurysm detection using local contrast normalization and local vessel detection [J].
Fleming, Alan D. ;
Philip, Sam ;
Goatman, Keith A. ;
Olson, John A. ;
Sharp, Peter F. .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2006, 25 (09) :1223-1232
[9]   Automated measurement of microaneurysm turnover [J].
Goatman, KA ;
Cree, MJ ;
Olson, JA ;
Forrester, JV ;
Sharp, PF .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (12) :5335-5341
[10]   Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema [J].
Haritoglou, Christos ;
Kook, Daniel ;
Neubauer, Aljoscha ;
Wolf, Armin ;
Priglinger, Siegfried ;
Strauss, Rupert ;
Gandorfer, Arnd ;
Ulbig, Michael ;
Kampik, Anselm .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (09) :999-1005